• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉器质性狭窄患者循环中可溶性 LR11 水平升高。

Enhanced circulating soluble LR11 in patients with coronary organic stenosis.

机构信息

Department of Cardiovascular Center, Sakura Hospital, Medical Center, Toho University, Chiba, Japan.

出版信息

Atherosclerosis. 2010 Jun;210(2):581-4. doi: 10.1016/j.atherosclerosis.2009.12.010. Epub 2009 Dec 16.

DOI:10.1016/j.atherosclerosis.2009.12.010
PMID:20047743
Abstract

LR11, an LDL receptor family member, is expressed in intimal smooth muscle cells. It was found that the soluble form of LR11 (sLR11) is detected in serum, and the circulating sLR11 levels are positively correlated with intima-media thickness of carotid arteries in dyslipidemic subjects. To clarify the significance of serum sLR11, the circulating sLR11 levels in patients with organic coronary stenosis and the contributing risk factors for them were studied. The subjects, 150 patients with symptoms of coronary artery disease, underwent coronary angiographic examination, and were divided into sex- and age-matched two groups; one is organic coronary stenosis group (OCS) and the other is normal coronary group (NC). Serum sLR11 levels were significantly higher in OCS than in NC (4.9+/-2.7 U vs 3.6+/-1.8 U, p<0.05). Multivariate regression analysis showed that circulating sLR11 is independent contributing factor for the OCS, as well as diabetes mellitus and dyslipidemia. Among various coronary risk factors for sLR11 level, HbA1c showed the highest correlation coefficient (p<0.01). These results suggest that the circulating sLR11 might reflect coronary organic stenosis, and that hyperglycemic condition might be promoting factor for expression of LR11 in intimal smooth muscle cells.

摘要

LR11 是 LDL 受体家族成员,在血管内膜平滑肌细胞中表达。研究发现,LR11 的可溶性形式(sLR11)存在于血清中,且血脂异常患者血清 sLR11 水平与颈动脉内-中膜厚度呈正相关。为明确血清 sLR11 的意义,研究了有器质性冠状动脉狭窄患者的循环 sLR11 水平及其相关的危险因素。对 150 例有冠心病症状的患者进行了冠状动脉造影检查,根据检查结果将患者分为两组,即有机冠状动脉狭窄组(OCS)和正常冠状动脉组(NC)。OCS 患者血清 sLR11 水平显著高于 NC 患者(4.9+/-2.7 U 比 3.6+/-1.8 U,p<0.05)。多变量回归分析表明,循环 sLR11 是 OCS 的独立危险因素,糖尿病和血脂异常也是其危险因素。在 sLR11 水平的各种冠状动脉危险因素中,HbA1c 的相关系数最高(p<0.01)。这些结果提示,循环 sLR11 可能反映了冠状动脉的器质性狭窄,高血糖状态可能是促进血管内膜平滑肌细胞中 LR11 表达的因素。

相似文献

1
Enhanced circulating soluble LR11 in patients with coronary organic stenosis.冠状动脉器质性狭窄患者循环中可溶性 LR11 水平升高。
Atherosclerosis. 2010 Jun;210(2):581-4. doi: 10.1016/j.atherosclerosis.2009.12.010. Epub 2009 Dec 16.
2
Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes.LR11(一种平滑肌细胞迁移调节剂)的循环可溶性形式是2型糖尿病患者颈动脉内膜中层厚度的新型标志物。
Clin Chim Acta. 2016 Jun 1;457:137-41. doi: 10.1016/j.cca.2016.04.016. Epub 2016 Apr 16.
3
Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury.循环可溶性LR11是平滑肌细胞增殖的一种新型标志物,在冠状动脉支架置入术后,其水平会因血管损伤而升高。
Atherosclerosis. 2014 Nov;237(1):374-8. doi: 10.1016/j.atherosclerosis.2014.08.044. Epub 2014 Sep 16.
4
Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.循环可溶性LR11对冠心病患者长期临床结局的预后影响。
Atherosclerosis. 2016 Jan;244:216-21. doi: 10.1016/j.atherosclerosis.2015.11.004. Epub 2015 Nov 6.
5
Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis.循环中可溶性 LR11 水平与颈动脉狭窄患者的动脉粥样硬化斑块高度相关,LR11 是一种调节平滑肌细胞迁移的蛋白。
Clin Chim Acta. 2019 Mar;490:69-76. doi: 10.1016/j.cca.2018.12.005. Epub 2018 Dec 12.
6
Increased circulating soluble LR11 in patients with acute coronary syndrome.急性冠脉综合征患者循环中可溶性 LR11 的增加。
Clin Chim Acta. 2013 Jan 16;415:191-4. doi: 10.1016/j.cca.2012.10.047. Epub 2012 Nov 2.
7
LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.LR11/SorLA将富含甘油三酯的脂蛋白与家族性高胆固醇血症(FH)患者发生心血管疾病的风险联系起来。
Atherosclerosis. 2015 Dec;243(2):429-37. doi: 10.1016/j.atherosclerosis.2015.10.009. Epub 2015 Oct 13.
8
Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease.可溶性LR11是川崎病后期血管病变的一种新型生物标志物。
Atherosclerosis. 2016 Mar;246:94-7. doi: 10.1016/j.atherosclerosis.2015.12.035. Epub 2015 Dec 29.
9
Enhanced circulating soluble LR11 in patients with diabetic retinopathy.糖尿病视网膜病变患者中循环可溶性 LR11 水平的升高。
Am J Ophthalmol. 2012 Jul;154(1):187-92. doi: 10.1016/j.ajo.2012.01.035. Epub 2012 Apr 27.
10
Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.测量可溶性LR11(动脉粥样硬化的循环标志物)及糖化血红蛋白(HbA1c)在家族性高胆固醇血症中的临床意义。
Clin Biochem. 2014 Sep;47(13-14):1326-8. doi: 10.1016/j.clinbiochem.2014.05.003. Epub 2014 May 22.

引用本文的文献

1
PAI-1 interaction with sortilin-related receptor 1 is required for lung fibrosis.肺纤维化需要纤溶酶原激活物抑制剂-1(PAI-1)与sortilin相关受体1相互作用。
JCI Insight. 2025 Apr 29;10(11). doi: 10.1172/jci.insight.186131. eCollection 2025 Jun 9.
2
Examination of a Low-density Lipoprotein Receptor Relative with 11 Ligand-binding Repeats (LR11) as a Biomarker in Esophageal Cancer.检测具有11个配体结合重复序列的低密度脂蛋白受体相关蛋白(LR11)作为食管癌生物标志物的研究
Juntendo Iji Zasshi. 2022 Oct 4;68(5):513-520. doi: 10.14789/jmj.JMJ22-0008-OA. eCollection 2022.
3
Diagnostic Value of sLR11 and sIL-2R in the Cerebrospinal Fluid for Malignant Central Nervous System Lymphoma.
脑脊液 sLR11 和 sIL-2R 对恶性中枢神经系统淋巴瘤的诊断价值。
Intern Med. 2024 Oct 15;63(20):2767-2771. doi: 10.2169/internalmedicine.3325-23. Epub 2024 Mar 4.
4
Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer's disease.发现备忘录:VPS10p-结构域受体在阿尔茨海默病中的多功能相互作用。
Mol Neurodegener. 2022 Nov 18;17(1):74. doi: 10.1186/s13024-022-00576-2.
5
Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients.可溶性 ST2 和可溶性 LR11 对腹膜透析患者死亡率和心血管事件的预后价值。
BMC Nephrol. 2020 Jun 15;21(1):228. doi: 10.1186/s12882-020-01886-7.
6
SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.SheddomeDB:膜结合脱落标志物的胞外域脱落数据库。
BMC Bioinformatics. 2017 Mar 14;18(Suppl 3):42. doi: 10.1186/s12859-017-1465-7.
7
Sorting receptor SORLA: cellular mechanisms and implications for disease.分选受体SORLA:细胞机制及其对疾病的影响
Cell Mol Life Sci. 2017 Apr;74(8):1475-1483. doi: 10.1007/s00018-016-2410-z. Epub 2016 Nov 10.
8
Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans.可溶性LR11/SorLA抑制脂肪组织中的产热作用,并与人类的体重指数相关。
Nat Commun. 2015 Nov 20;6:8951. doi: 10.1038/ncomms9951.
9
Vitreous fluid and circulating levels of soluble lr11, a novel marker for progression of diabetic retinopathy.玻璃体液和循环可溶性 lr11 水平,一种糖尿病视网膜病变进展的新型标志物。
Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):2689-95. doi: 10.1007/s00417-013-2373-9. Epub 2013 May 8.